Concepedia

Bryan Ciccarelli

BC

20

Publications

1.6K

Citations

17

H-Index

2007

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

Centre Hospitalier Universitaire de Lille

Bryan Ciccarelli is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2007–2020

20

Publications

20

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism

Evdoxia Hatjiharissi, Lian Xu, Daniel Santos et al. · Blood · 2007 · 260 citations · Full text

A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita Singh, Monette Aujay et al. · Blood · 2010 · 216 citations · Full text

Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs

Xavier Leleu, Jacob D. Soumerai, Aldo M. Roccaro et al. · Journal of Clinical Oncology · 2008 · 182 citations · Full text

miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

Jianjun Zhao, Jianhong Lin, Di Zhu et al. · Cancer Research · 2014 · 180 citations · Full text

Thalidomide and rituximab in Waldenstrom macroglobulinemia

Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan et al. · Blood · 2008 · 143 citations · Full text

Rows per page

1–5 of 20